ClinConnect ClinConnect Logo
Search / Trial NCT06625554

Urinary Tract Infection In Assiut University Children Hospital

Launched by ASSIUT UNIVERSITY · Oct 1, 2024

Trial Information

Current as of August 24, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding urinary tract infections (UTIs) in children at Assiut University Children Hospital. Researchers want to learn more about the types of bacteria that cause these infections and how sensitive they are to different antibiotics. This information can help doctors choose the best treatment for children with UTIs.

To participate in this study, children must be between 1 month and 17 years old and have been diagnosed with a urinary tract infection. Unfortunately, newborns and children with chronic kidney diseases won't be eligible, nor will those who choose not to take part. If your child is eligible and decides to join, they will contribute to important research that could improve how UTIs are treated in the future. The trial is not yet recruiting participants, so more information will be shared when it begins.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1-Children over 1 month and less than 18 year of age. 2-Diagnosed cases of Urinary Tract Infection. 3-who accepted to participate in the study.
  • Exclusion Criteria:
  • 1-neonates and patients more than 18 year. 2-children with chronic kidney diseases. 3-who refused to participate in our study.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported